Continuous glucose monitoring using the glucose sensor CGMS® during betamethasone therapy in non-diabetic pregnant women;Glukosemessung mit dem kontinuierlich messenden glukosesensor CGMS® bei stoffwechselgesunden schwangeren während betamethasontherapie zur fetalen lungenreifeinduktion

Zeitschrift fur Geburtshilfe und Neonatologie

Volumn 210, Issue 5, 2006, Pages 184-190

  Schumacher, A ^a   Sidor, J ^b   Bühling, Kai J ^a,c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b ST JOSEPH KRANKENHAUS   (Germany)

^c Gemeinschaftspraxis BKS   (Germany)

Author keywords

Antenatal glucocorticoids; Betamethasone; Maternal hyperglycemia; Pregnancy; Preterm birth

Indexed keywords

BETAMETHASONE; GLUCOSE;

APGAR SCORE; ARTICLE; BIRTH WEIGHT; BODY HEIGHT; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; FETUS OUTCOME; GLUCOSE BLOOD LEVEL; HEAD CIRCUMFERENCE; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; KETOACIDOSIS; KETONURIA; NEWBORN; ORAL GLUCOSE TOLERANCE TEST; PATIENT MONITORING; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN;

ADULT; BETAMETHASONE; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES, GESTATIONAL; FEMALE; GLUCOCORTICOIDS; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; TREATMENT OUTCOME;

EID: 33845273541     PISSN: 09482393     EISSN: 14391651     Source Type: Journal    
DOI: 10.1055/s-2006-951743     Document Type: Article

References (22)

1. National Institutes of Health (NIH) Consensus Development Conference Statement. Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consens Statement, 1994; 12: 1-24
2. Leviton LC, Baker S, Hassol A, Goldenberg RL. An exploration of opinion and practice patterns affecting low use of antenatal corticosteroids. Am J Obstet Gynecol 1995; 173: 312-316
3. Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respirartory distress syndrome in premature infants. Pediatrics 1972; 50: 515-525
4. Crowley P. Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994. Am J Obstet Gynecol 1995; 173: 322-335
5. Borberg C, Gillmer MD, Beard RW, Oakley NW. Metabolic effects of beta-sympathomimetic drugs and dexamethasone in normal and diabetic pregnancy. Br J Obst Gynaecol 1978; 85: 184-189
6. Star J, Hogan J, Sosa ME, Carpenter MW. Glucocorticoid-associated maternal hyperglycemia: a randomized trial of insulin prophylaxis. J Maternal Fetal Med. 2000; 9: 273-277
7. Amorim MM, Santos LC, Faundes A. Corticosteroid therapy for prevention of respiratory distress syndrome in severe preeclampsia. Am J Obstet Gynecol 1999; 180: 1283-1288
8. Fisher JE, Smith RS, Lagrandeur R, Lorenz RP. Gestational diabetes mellitus in women receiving beta-adrenergics and corticosteroids for threatened preterm delivery. Obstet Gynecol 1997; 90: 880-883
9. Bouhanick B, Biquard F, Hadjadj S, Roques MA. Does treatment with antenatal glucocorticoids for the risk of premature delivery contribute to ketoacidosis in pregnant women with diabetes who receive continuous subcutaneous insulin infusion (CSII)?. Arch Intern Med 2000; 160: 242-243
10. Bernstein IM, Catalano PM. Ketoacidosis in pregnancy associated with the parenteral administration of terbutaline and betamethasone. A case report J Reprod Med 1990; 35: 818-820
11. French NP, Hagan R, Evans SF, Godfrey M, Newnham JP. Repeated antenatal corticosteroids: size at birth and subsequent development. Am J Obstet Gynecol 1999; 180: 114-21
12. Newnham JP, Moss TJ, Nitsos I, Sloboda DM. Antenatal corticosteroids: the good, the bad and the unknown. Curr Opin Obstet Gynecol 2002; 14: 607-612
13. Larsen R. Störungen des Säure-Basen-Gleichgewichts. In: Larsen R (Hrsg.). Anästhesie; 5. Auflage München, Wien, Baltimore: Urban und Schwarzenberg, 1995: 346-350
14. Carpenter M, Coustan D. Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 1982; 144: 768-773
15. Roemer VM, Pfeiffer KH. Über den Einfluss der intrauterinen Mangelentwicklung und der Gestationsdauer auf den Status praesens des Neugeborenen. Geburtshilfe u. Frauenheilkunde 1990; 50: 124-131
16. Voigt M, Friese K, Schneider KTM, Jorch G, Hesse V. Kurzmitteilung zu den Perzentilwerten für die Körpermaße Neugeborener. Geburtsh Frauenheilk 2002; 62: 274-276
17. Adam K, Ou CN, Cotton DB. Combined effect of terbutaline and betamethasone on glucose homeostasis in preterm labor. Fetal Diagn Ther 1993; 8: 187-194
18. Mastrobattista JM, Patel N, Monga M. Betamethasone alteration of the one-hour glucose challenge test in pregnancy. J Reprod Med 2001; 46: 83-86
19. Bühling KJ, Stein U, Dudenhausen JW. Evaluation des 50g-Glukose-Screeningtests an 1416 Schwangeren. Geburtsh u Frauenheilk 1998; 58: 100-109
20. Rizzo T, Metzger BE, Burns WJ, Burns K. Correlations between antepartum maternal metabolism and child intelligence. N Engl J Med 1991; 325: 911-916
21. Phuapradit W, Saropala N, Roungsipragarn R. Diabetic ketoacidosis in pregnancy. J Med Assoc Thai 1993; 76: 288-291
22. Dessens AB, Haas HS, Koppe JG. Twenty-year follow-up of antenatal corticosteroid treatment. Pediatrics 2000; 105: E77